UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000008736
Receipt number R000010108
Scientific Title Efficacy of Esmeprazole and Lansoprazole in patients with upper gastrointestinal symptpms taking non-steroida anti-inflammatory drugs
Date of disclosure of the study information 2012/08/20
Last modified on 2012/08/20 20:00:02

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Efficacy of Esmeprazole and Lansoprazole in patients with upper gastrointestinal symptpms taking non-steroida anti-inflammatory drugs

Acronym

Efficacy of Esmeprazole and Lansoprazole

Scientific Title

Efficacy of Esmeprazole and Lansoprazole in patients with upper gastrointestinal symptpms taking non-steroida anti-inflammatory drugs

Scientific Title:Acronym

Efficacy of Esmeprazole and Lansoprazole

Region

Japan


Condition

Condition

(1)continuous in use about NSAIDs aged 20 and over.
(2) The patient who has an anamnesis of digestive ulcer.
(3) The patient at least whose one item it is at the research registration time and is three or more points in the question item of a GOS interview sheet.
(4) Those by whom the consent of research participation was got with the document.

Classification by specialty

Gastroenterology Orthopedics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

It is examined how the GOS abdominal-symptoms synthesis score at the time of start of the research changes in an example while using NSAIDs by medication of 20 mg of Esomeprasolof two weeks after, or 15 mg of run Soprasole.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

Global Overall Symptom scale

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -participants are blinded

Control

Active

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

No need to know


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

A group (Esomeprazole medication)
Esomeprazole 20mg once before breakfast for 2weeks

Interventions/Control_2

B group (Lansoprazole medication) groups.
Lansoprazole 15mg once before breakfast for two weeks

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

(1) He is man and woman continuous in use about NSAIDs aged 20 and over.
(2) The patient who has an anamnesis of digestive ulcer.
(3) The patient at least whose one item it is at the research registration time and is three or more points in the question item of a GOS interview sheet.
(4) Those by whom the consent of research participation was got with the document.

Key exclusion criteria

Except the above

Target sample size

400


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Yuji Uchio

Organization

Shimane University School of Medicine

Division name

Department of Orthopaedic Surgery

Zip code


Address

89-1Enyacho Izumo City

TEL

0853-20-2242

Email



Public contact

Name of contact person

1st name
Middle name
Last name Yuji Uchio

Organization

Shimane University School of Medicine

Division name

Department of Orthopaedic Surgery

Zip code


Address


TEL


Homepage URL


Email

uchio@med.shimane-u.ac.jp


Sponsor or person

Institute

Department of Orthopaedic Surgery Shimane University School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Department of Orthopaedic Surgery Shimane University School of Medicine

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

島根大学医学部附属病院、出雲市立総合医療センター 松江赤十字病院 隠岐病院 かじたに整形外科医院 かつべ整形外科医院 えだクリニック 平成記念病院 出雲市民病院 浜田医療センター(島根県) 若草第一病院(大阪府)IHI播磨病院(兵庫県)


Other administrative information

Date of disclosure of the study information

2012 Year 08 Month 20 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2012 Year 06 Month 27 Day

Date of IRB


Anticipated trial start date

2012 Year 08 Month 20 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2012 Year 08 Month 20 Day

Last modified on

2012 Year 08 Month 20 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000010108


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name